Study #2024-0412
NCI PBTC-048: Feasibility trial of Optune for children with recurrent or progressive supratentorial high-grade glioma or ependymoma, and feasibility and efficacy trial of Optune in conjunction with radiation therapy for children with newly diagnosed DIPG
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Study phase:
Physician name:
Susan McGovern
Department:
Radiation Oncology
For general questions about clinical trials:
1-844-961-3045
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.